Tim Williams - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Tim Williams's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Tim Williams

Tim Williams

Verified

Senior Manager , Global Social Media, CSL

Pittsburgh

Biography

Digital Content Manager at KDKA, CBS Pittsburgh.

Final Covers

Gadgets, Education, Smartphones , Health, General News , Consumer

Doesn’t Cover

Industrial

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 494

  • Mass. governor: Lead pipe replacement funding delay is 'dangerous'

    By Tim Williams| Spectrum News 1 Central NY Verified On Tuesday, some of the highest-ranking Massachusetts elected officials including Gov.

    By Tim Williams · Spectrum News 1 Central NY

    Mar. 26, 2025

  • Pirates Prospect Watch: Five Standouts From the Spring Breakout Game

    By Tim Williams| Pirates Prospect@ Prospect Watch Published:March 15, 2025 Reading time: 5 min. By Tim WilliamsThe Pittsburgh Pirates took on the Philadelphia Phillies in the second annual Spring Breakout game on Friday, putting the prospects of each organization against each other on MLB Network. While the game had the televised feel of a real game, it allowed backfield rules to take place. This was on display with Anthony Solometo, who was removed early in the third inning, due to a high pitch count.

    By Tim Williams · Pirates Prospect

    Mar. 15, 2025

  • Mass. governor: Lead pipe replacement funding delay is 'dangerous'

    By Tim Williams| Spectrum News 1 Central NY Verified On Tuesday, some of the highest-ranking Massachusetts elected officials including Gov.

    By Tim Williams · Spectrum News 1 Central NY

    Mar. 26, 2025

As seen in

Company Info

CSL

CSL, headquartered in Melbourne, Australia, is a global biotechnology leader with operations in over 30 countries. Founded in 1916 and privatized in 1994, CSL develops and manufactures biotherapeutics, vaccines, and specialty pharmaceuticals aimed at treating rare and serious medical conditions. The company employs more than 32,000 people and reported $14.8 billion in revenue in 2024. CSL operates through four main divisions: CSL Behring, which specializes in plasma-derived therapies; CSL Plasma, which manages plasma collection networks; CSL Seqirus, a major producer of influenza vaccines; and CSL Vifor, focusing on therapies for iron deficiency and kidney disease. The company offers a range of products, including immunoglobulins, seasonal and pandemic vaccines, and iron deficiency treatments. CSL is committed to quality and innovation, maintaining a strong focus on patient needs and compliance with global regulatory standards.

Melbourne, Victoria, Australia

'+61 3 9389 1911

Founded: 1916